A new coalition has been established to advocate for improvements in access to radiation oncology.
-
Latest News
Another reform process fails - how many times does this need to happen?
Does the minister understand that this latest failure is symptomatic of a broader problem with policy design? Does he have confidence in the development and implementation of policy responses to the reviews of health technology assessment, chemotherapy, and immunisation?
-
Latest News New coalition established to advocate for action on radiation therapy May 2, 2024
-
Latest News Illumina partners with the Garvan on major new genome project May 2, 2024Global genomics company Illumina is partnering with the Garvan Institute of Medical Research’s TenK10K project on a joint $27 million investment to map 50 million human cells from 10,000 people.
-
Latest News The term 'independent' is used to absolve decision-makers of responsibility May 1, 2024Describing the PBAC as independent is akin to telling a company's employees they are independent—they operate within a pre-determined framework imposed by management. They are independent to the extent the management permits.
-
Podcast The 'Week in Review' Podcast - 26 April April 28, 2024The importance of scrutinising data-related claims, particularly in health care, and the double standard regarding productivity. Kudos to a company for welcoming a new listing but calling out that it has taken over 650 days since TGA registration. The challenge of social media for vulnerable communities.
-
Latest News Pfizer welcomes PBS listing of therapy for rare heart condition May 1, 2024Pfizer Australia and New Zealand Managing Director Anne Harris said, “Pfizer’s purpose is to deliver breakthrough medicines that change patients’ lives."
-
Latest News 'The journey for people living with severe psoriasis can be long and difficult' May 1, 2024AbbVie has welcomed today’s listing on the PBS of a single dose injection of its biologic SKYRIZI (risankizumab) for severe plaque psoriasis.
-
Latest News First in class therapy for obstructive hypertrophic cardiomyopathy now reimbursed May 1, 2024Australia’s first cardiac myosin inhibitor for the treatment of adults with symptomatic New York Heart Association class II-III obstructive hypertrophic cardiomyopathy is now reimbursed via the PBS.
-
Latest News 'Important for me to share the full picture as we must never allow it to happen again' April 30, 2024"I'm a mother who gave up a very comfortable corporate gig to fight for the lives of others. It has always been about saving these babies and giving children a chance to grow up. It has come at a huge cost to me financially, emotionally and physically in the time that I fought for those living with SMA to get access," said Fiona Tolich.
-
Latest News Summit's day one provided critical lessons for both sides of the Tasman April 30, 2024From the first day of the 'Valuing Life—Medicines Access Summit' in Wellington, both sides of the Tasman gained some critical insights.
-
Latest News NZ Government commits new funding to address Pharmac's 'fiscal cliff' April 29, 2024“In a trying fiscal environment, the Government has to prioritise. Making sure that New Zealanders have access to the medicines they need for a fulfilling life is one of our greatest priorities," said Associate Health Minister David Seymour.
-
Latest News NZ Government appoints former Deputy PM new chair of Pharmac April 29, 2024The new Chair will exercise significant authority as the controversial agency works to recover from recent scandals involving the organisation's staff, including chief executive Sarah Fitt.
-
Latest News The listing will 'benefit thousands of Australian women', says Mark Butler April 29, 2024Health Minister Mark Butler has announced that the PBS listing of Lilly's VERZENIO will be expanded on 1 May to include an invasive form of early breast cancer.
-
Latest News 'An important first step to achieving reimbursed access for eligible patients in Australia' April 28, 2024The Pharmaceutical Benefits Advisory Committee recommended listing new medicines for endometriosis, breast cancer, and a range of other conditions and expanding the listing of others.
-
Latest News Let's make decisions based on credible information and not guesswork April 24, 2024The claims surrounding health system carbon emissions are being used to push significant changes in funding decisions and care delivery but rely on unpublished data, woolly assumptions and implausible assertions.
-
Latest News Productivity Commission research backs the benefit of faster access to medicines April 26, 2024Medicines Australia CEO Liz de Somer said, "The Productivity Commission research recognises that advances in cancer treatments have been one of the major drivers of productivity growth, and this is consistent with productivity studies from overseas."
-
Latest News New research shows adult vaccination programs deliver major return on investment April 26, 2024Medicines Australia says a new report has revealed the significant benefits of investing in adult vaccination programs.
-
Latest News 'The Pharmac system again, over about 33 years old, hasn’t really changed and evolved' April 24, 2024AstraZeneca has released a new episode of its recently launched TrailblAZers video podcast featuring New Zealand MP Todd Stephenson.
-
Latest News AusBiotech appoints experienced Sanofi leader as its new chief executive April 23, 2024The association's newly-appointed leader said, “I’m honoured to join AusBiotech as its incoming CEO, and to help the team build on the outstanding work delivered for members every day.”
-
Latest News Tour de Cure backs further development of Noxopharm's preclinical brain cancer candidate April 24, 2024Noxopharm CEO Dr Gisela Mautner said, “We are very grateful to the Tour de Cure team for funding this promising research. With this grant, our preclinical drug candidate is recognised as having potential that warrants further investigation and development."
Australian Biotech
-
Tour de Cure backs further development of Noxopharm's preclinical brain cancer candidate
April 24, 2024 -
Tour de Cure backs further development of Noxopharm's preclinical brain cancer candidate
April 22, 2024 -
Seaport Therapeutics receives $100 million in funding to maximise Monash invention
April 15, 2024 -
Monash Partners Comprehensive Cancer Consortium awards precision medicine grants
April 10, 2024 -
Chimeric secures US patent for its CHM 0201 cell therapy platform technology
April 8, 2024
Other Health
-
Bupa Ventures to invest $20m to accelerate healthcare innovations
February 12, 2024 -
Medibank offering members $50 to put towards dental out-of-pocket costs
February 7, 2024 -
US FDA approves Edwards' Evoque system for major heart valve disease
February 7, 2024 -
Private health insurers say price gouging doctors should be named and shamed
February 7, 2024 -
Medibank releases its top private health insurance claims for 2023
December 13, 2023
Latest Video
New Stories
-
Another reform process fails - how many times does this need to happen?
May 2, 2024 - - Latest News -
New coalition established to advocate for action on radiation therapy
May 2, 2024 - - Latest News -
Illumina partners with the Garvan on major new genome project
May 2, 2024 - - Latest News -
The term 'independent' is used to absolve decision-makers of responsibility
May 1, 2024 - - Latest News -
'The journey for people living with severe psoriasis can be long and difficult'
May 1, 2024 - - Latest News -
Pfizer welcomes PBS listing of therapy for rare heart condition
May 1, 2024 - - Latest News -
First in class therapy for obstructive hypertrophic cardiomyopathy now reimbursed
May 1, 2024 - - Latest News